Narae Nanotech

At a glance

Narae Nanotech filed 54 disclosures in the last 12 months, including 15 insider, 6 contract, 4 buyback, 2 5% holder and 2 m&a. The most recent key filing was on Oct 22: President bought 1,000 sh on the market at an average ₩6,596, Oct 19–21.

Revenue for 2025 was ₩54.5B, up 34.8% on 2024. It made an operating loss of ₩8.8B. Debt was 71% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩38B and operating profit of ₩3.7B.

The 2025 annual report lists 155 employees with an average tenure of 5.8 years and average pay of ₩52.4M, #1342 of 1,829 listed companies by average pay. Its 8 directors and auditors were paid ₩74M each on average. It paid no cash dividend for 2025. 김민호 and related parties held 47.99% at year end.

From the 2025 annual report

Staff: 155 (130 men, 25 women), of whom 6 on fixed-term contracts. Total pay for the year: ₩8.6B. Directors and auditors: 8, paid ₩516M in total.

No cash dividend was paid for 2025.

Largest shareholder

김민호 holds 39.79%; with 13 related parties the group holds 47.99% of common shares at year end (from 45.58% at the start of the year).

Auditor: 인덕회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

New contracts, last 12 months

1 new supply contract worth 11% of the revenue stated in the filings.

Amended amounts replace the originals. Subsidiary contracts and terminations are excluded.

Financial summary